Planning and Execution of Internal Audits in Pharmaceuticals

  • Home
  • Planning and Execution of Internal Audits in Pharmaceuticals

Planning and Execution of Internal Audits in Pharmaceuticals

Planning and Execution of Internal Audits in Pharmaceuticals

Internal audits (self-inspections) are a key part of a pharmaceutical Quality Management System (QMS). They ensure compliance with cGMP, regulatory guidelines, and company SOPs, while also driving continuous improvement.


1. Planning the Internal Audit

a. Define Objectives & Scope

  • Verify compliance with GMP, SOPs, and regulatory requirements.

  • Identify gaps, risks, and opportunities for improvement.

  • Scope may include manufacturing, QC labs, warehouse, engineering, or QMS processes.

b. Prepare the Audit Schedule

  • Develop an annual audit calendar covering all critical departments.

  • Prioritize high-risk areas (sterile manufacturing, data integrity, deviations).

  • Inform auditees in advance (unless it’s an unannounced audit).

c. Select and Train Auditors

  • Choose auditors who are independent of the audited area.

  • Provide training in GMP guidelines, auditing techniques, and communication skills.

d. Pre-Audit Preparation

  • Review previous audit reports, CAPAs, and regulatory findings.

  • Develop checklists tailored to each department/process.

  • Gather reference documents (SOPs, policies, regulatory guidelines).


2. Execution of the Internal Audit

a. Opening Meeting

  • Introduce the audit team and explain audit objectives, scope, and methodology.

  • Set expectations and communication flow.

b. On-Site Audit Activities

  • Observe facilities, equipment, and processes.

  • Review documents: batch records, logbooks, calibration, deviations, CAPAs.

  • Interview employees to confirm knowledge of SOPs and GMP compliance.

  • Collect objective evidence (facts, not opinions).

c. Recording Observations

  • Classify findings into:

    • Critical – Major impact on patient safety/product quality.

    • Major – Significant deviation from GMP but not immediately critical.

    • Minor – Limited risk, requires correction.

d. Closing Meeting

  • Present findings to management.

  • Discuss observations clearly and factually.

  • Agree on timelines for corrective and preventive actions (CAPA).


3. Post-Audit Activities

a. Audit Report

  • Prepare a formal report documenting scope, findings, and evidence.

  • Categorize observations by severity.

  • Circulate to concerned departments and senior management.

b. CAPA Management

  • Auditees prepare a CAPA plan for each finding.

  • Define root cause, corrective action, preventive action, and timelines.

  • Submit responses within the defined timeline (e.g., 15–30 days).

c. Follow-Up & Closure

  • QA verifies CAPA implementation and effectiveness.

  • Conduct re-audits if required.

  • Officially close the audit once compliance is demonstrated.


Summary:
Effective planning (scope, schedule, training, checklist) and structured execution (observation, documentation, CAPA) of internal audits ensure regulatory compliance, continuous improvement, and patient safety.

🎓 Discover one of the best Complete Pharmaceutical Quality Assurance Course available —click below to explore the course that’s shaping future in QA Course skills.

https://trcjw.on-app.in/app/oc/306166/trcjw?utm_source%3Dcopy-link%26utm_medium%3Dtutor-course-referral%26utm_campaign%3Dcourse-overview-app

Submit a Comment

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.

Hello
Chat now via Whatsapp